Silence Therapeutics
SLN
$23.00
Share price
0.26%
Change (1 day)
322.02%
Change (1 year)
Categories
Operating Margin for Silence Therapeutics (SLN)
Operating Margin as of May 2024 (TTM): -267.78%
According to Silence Therapeutics's latest financial reports and stock price the company's current Operating Margin is -267.78%. At the end of 2021 the company had an Operating Margin of -369.30%.
Operating Margin history for Silence Therapeutics from 2021 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -369.30% | -43.83% |
| 2020 | -657.51% | -92.97% |
| 2019 | -9,359.43% | |
| 2017 | -23,500.00% | 1419.82% |
| 2016 | -1,546.23% | |
| 2014 | -80,846.67% | 942.67% |
| 2013 | -7,753.85% | -51.91% |
| 2012 | -16,125.15% | 1855.08% |
| 2011 | -824.78% | 123.48% |
| 2010 | -369.06% | -2.53% |
| 2009 | -378.64% | 6.36% |
| 2008 | -356.00% | 155.72% |
| 2007 | -139.21% | -31.19% |
| 2006 | -202.31% | -71.66% |
| 2005 | -713.95% | -64.92% |
| 2004 | -2,035.22% | 924.08% |
| 2003 | -198.74% | 14.09% |
| 2002 | -174.20% | -92.06% |
| 2001 | -2,193.48% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.